Encouraging the Alabama Medicaid Agency to evaluate the overall costs of GLP-1 medications and report its findings

SJR 60 is a resolution encouraging the Alabama Medicaid Agency to evaluate the costs of GLP-1 medications (used for weight management) and report findings to the legislature. It asks Medicaid to assess potential program savings, analyze coverage costs against new federal drug pricing models, and consult with stakeholders to determine if these medications could improve health outcomes while reducing costs. The resolution specifically directs the agency to report its findings before the 2027 legislative session. This is a non-binding request, not a law requiring coverage, and it directly affects Alabama Medicaid's operations and future budget planning.